The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Arsenic Trioxide as an Inducer of Apoptosis and Loss of PML/RARα Protein in Acute Promyelocytic Leukemia Cells
Open accessAbstract
BACKGROUND: Retinoids, which are derivatives of vitamin A, induce differentiation of acute promyelocytic leukemia (APL) cells in vitro and in patients. However, APL cells develop resistance to retinoic acid treatment. Arsenic trioxide (As2O3) can induce clinical remission in patients with APL, including those who have relapsed after retinoic acid treatment, by inducing apoptosis (programmed cell death) of the leukemia cells. In this study, we investigated the molecular mechanisms by which As2O3 induces apoptosis in retinoic acid-sensitive NB4 APL cells, in retinoic acid-resistant derivatives of these cells, and in fresh leukemia cells from patients. METHODS: Apoptosis was assessed by means of DNA fragmentation analyses, TUNEL assays (i.e., deoxyuridine triphosphate labeling of DNA nicks with terminal deoxynucleotidyl transferase), and flow cytometry. Expression of the PML/RAR alpha fusion protein in leukemia cells was assessed by means of western blotting, ligand binding, and immunohistochemistry. Northern blotting and ribonuclease protection assays were used to evaluate changes in gene expression in response to retinoic acid and As2O3 treatment. RESULTS AND CONCLUSIONS: As2O3 induces apoptosis without differentiation in retinoic acid-sensitive and retinoic acid-resistant APL cells at concentrations that are achievable in patients. As2O3 induces loss of the PML/RAR alpha fusion protein in NB4 cells, in retinoic-acid resistant cells derived from them, in fresh APL cells from patients, and in non-APL cells transfected to express this protein. As2O3 and retinoic acid induce different patterns of gene regulation, and they inhibit the phenotypes induced by each other. Understanding the molecular basis of these differences in the effects of As2O3 and retinoic acid may guide the clinical use of arsenic compounds and provide insights into the management of leukemias that do not respond to retinoic acid.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
Melton, D. A., Krieg, P. A., Rebagliati, M. R., Maniatis, T., Zinn, K., & Green, M. R. (1984) · Nucleic Acids Research · doi:10.1093/nar/12.18.7035 · Cited by 6,324
Shen, Z.-X., Chen, G.-Q., Ni, J.-H., Li, X.-S., Xiong, S.-M., Qiu, Q.-Y., Zhu, J., Tang, W., Sun, G.-L., Yang, K.-Q., et al. (1997) · Blood · doi:10.1182/blood.v89.9.3354 · Cited by 1,428
Kakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
Self-citationde Thé, H., Lavau, C., Marchio, A., Chomienne, C., Degos, L., & Dejean, A. (1991) · Cell · doi:10.1016/0092-8674(91)90113-d · Cited by 1,343
Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251
Self-citationCastaigne, S., Chomienne, C., Daniel, M., Ballerini, P., Berger, R., Fenaux, P., & Degos, L. (1990) · Blood · doi:10.1182/blood.v76.9.1704.1704 · Cited by 1,184
Identification of two distinct regulatory regions adjacent to the human β-interferon gene
Zinn, K., Dimaio, D., & Maniatis, T. (1983) · Cell · doi:10.1016/0092-8674(83)90544-5 · Cited by 1,038
Lanotte, M., Martin-Thouvenin, V, Najman, S., Balerini, P., Valensi, F., & Berger, R. (1991) · Blood · doi:10.1182/blood.v77.5.1080.1080 · Cited by 883
Chen, G., Zhu, J., Shi, X., Ni, J., Zhong, H., Si, G., Jin, X., Tang, W., Li, X., Xong, S., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1052.1052 · Cited by 864
A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein
Dyck, J. A., Maul, G. G., Miller, W. H., Chen, J. D., Kakizuka, A., & Evans, R. M. (1994) · Cell · doi:10.1016/0092-8674(94)90340-9 · Cited by 785
Self-citationChen, G., Shi, X., Tang, W., Xiong, S. M., Zhu, J., Cai, X., Han, Z., Ni, J.-H., Shi, G., Jia, P.-M., et al. (1997) · PubMed · Cited by 781
Self-citationHe, L.-Z., Figueiredo-Pontes, L. L., Rego, E. M., & Pandolfi, P. P. (2015) · Encyclopedia of Cancer · doi:10.1007/978-3-662-46875-3_63 · Cited by 766
Weis, K., Rambaud, S., Lavau, C., Jansen, J., Carvalho, T., Carmo-Fonseca, M., Lamond, A., & Dejean, A. (1994) · Cell · doi:10.1016/0092-8674(94)90341-7 · Cited by 652
Grignani, F., Ferrucci, P. F., Testa, U., Talamo, G., Fagioli, M., Alcalay, M., Mencarelli, A., Grignani, F., Peschle, C., Nicoletti, I., et al. (1993) · Cell · doi:10.1016/0092-8674(93)80044-f · Cited by 583
Self-citationAcute promyelocytic leukemia: from genetics to treatment
Grignani, F., Fagioli, M., Alcalay, M., Longo, L., Pandolfi, P., Donti, E., Biondi, A., Lo Coco, F., Grignani, F., & Pelicci, P. (1994) · Blood · doi:10.1182/blood.v83.1.10.10 · Cited by 494
Self-citationZhu, J., Koken, M. H. M., Quignon, F., Chelbi-Alix, M. K., Degos, L., Wang, Z. Y., Chen, Z., & de Thé, H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3978 · Cited by 427
Kastner, P., Perez, A., Lutz, Y., Rochette-Egly, C., Gaub, M. P., Durand, B., Lanotte, M., Berger, R., & Chambon, P. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05095.x · Cited by 415
Chen, Z., Xue, Y., Zhang, R., Tao, R., Xia, X., Li, C., Wang, W., Zu, W., Yao, X., & Ling, B. (1991) · Blood · doi:10.1182/blood.v78.6.1413.1413 · Cited by 399
Degos, L., Dombret, H., Chomienne, C., Daniel, M., Miclea, J., Chastang, C., Castaigne, S., & Fenaux, P. (1995) · Blood · doi:10.1182/blood.v85.10.2643.bloodjournal85102643 · Cited by 362
Biochemistry of the Essential Ultratrace Elements
(1984) · Springer eBooks · doi:10.1007/978-1-4684-4775-0 · Cited by 327
Pandolfi, P. P., Grignani, F., Alcalay, M., Mencarelli, A., Biondi, A., Lo‐Coco, F., Grignani, F., & Pelicci, P. G. (1991) · PubMed · Cited by 305
Self-citationPMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.
Perez, A., Kastner, P., Sethi, S., Lutz, Y., Reibel, C., & Chambon, P. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05986.x · Cited by 292
PML, a growth suppressor disrupted in acute promyelocytic leukemia.
Mu, Z. M., Chin, K. V., Liu, J. H., Lozano, G., & Chang, K. S. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.10.6858 · Cited by 288
Tumor-suppressive effect of the retinoic acid receptor beta in human epidermoid lung cancer cells.
Houle, B., Rochette-Egly, C., & Bradley, W. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.985 · Cited by 280
PML protein expression in hematopoietic and acute promyelocytic leukemia cells
Daniel, M., Koken, M., Romagne, O., Barbey, S., Bazarbachi, A., Stadler, M., Guillemin, M., Degos, L., Chomienne, C., & de The, H. (1993) · Blood · doi:10.1182/blood.v82.6.1858.1858 · Cited by 251
Yoshida, H., Kitamura, K., Tanaka, K., Ōmura, S., Miyazaki, T., Hachiya, T., Ohno, R., & Naoe, T. (1996) · PubMed · Cited by 249
The PML growth-suppressor has an altered expression in human oncogenesis.
Koken, M. H. M., Linares‐Cruz, G., Quignon, F., Viron, A., Chelbi‐Alix, M. K., Sobczak‐Thépot, J., Juhlin, L., Degos, L., Calvo, F. M., & de Thé, H. (1995) · PubMed · Cited by 231
Xu, X.-C., Sozzi, G., Lee, J. S., Lee, J. J., Pastorino, U., Pilotti, S., Kurie, J. M., Hong, W. K., & Lotan, R. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.9.624 · Cited by 201
Raelson, J., Nervi, C., Rosenauer, A., Benedetti, L., Monczak, Y., Pearson, M., Pelicci, P., & Miller, W. J. (1996) · Blood · doi:10.1182/blood.v88.8.2826.bloodjournal8882826 · Cited by 197
Self-citationLee, T.-C., Oshimura, M., & Barrett, J. C. (1985) · Carcinogenesis · doi:10.1093/carcin/6.10.1421 · Cited by 187
Shao, W., Benedetti, L., Lamph, W. W., Nervi, C., & Miller, W. H. (1997) · Blood · doi:10.1182/blood.v89.12.4282 · Cited by 146
Self-citationDrach, J. W., McQueen, T. J., Engel, H., Andreeff, M., Robertson, K. A., Collins, S. J., Malavasi, F., & Mehta, K. (1994) · PubMed · Cited by 129
Phosphorylation of the retinoic acid receptor-alpha by protein kinase A
Rochette-Egly, C. (1995) · Molecular Endocrinology · doi:10.1210/me.9.7.860 · Cited by 124 · cited 1×
“The membranes were probed with an antibody directed against the RARa F domain [provided by P. Chambon ( 28 )] (1:1000 antibody dilution), and antibody binding was detected with the ECL chemiluminescence system (Amersham Life Science Inc., Arlington Heights, IL).”
MethodFlenghi, L., Fagioli, M., Tomassoni, L., Pileri, S. A., Gambacorta, M., Pacini, R., Grignani, F., Casini, T., Ferrucci, P. F., Martelli, M., et al. (1995) · Blood · doi:10.1182/blood.v85.7.1871.bloodjournal8571871 · Cited by 102
Self-citationDermime, S., Grignani, F., Clerici, M., Nervi, C., Sozzi, G., Talamo, G., Marchesi, E., Formelli, F., Parmiani, G., Pelicci, P. G., et al. (1993) · Blood · doi:10.1182/blood.v82.5.1573.1573 · Cited by 100
Self-citationNervi, C., Grippo, J. F., Sherman, M. I., George, M. D., & Jetten, A. M. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.15.5854 · Cited by 96
Self-citationMiller, W. J., Jakubowski, A., Tong, W., Miller, V., Rigas, J., Benedetti, F. M., Gill, G., Truglia, J., Ulm, E. H., & Shirley, M. A. (1995) · Blood · doi:10.1182/blood.v85.11.3021.bloodjournal85113021 · Cited by 86
Self-citationBenedetti, L., Grignani, F., Scicchitano, B., Jetten, A. M., Diverio, D., Coco, F. L., Avvisati, G., Gambacorti-Passerini, C. B., Adamo, S., Levin, A., et al. (1996) · Blood · doi:10.1182/blood.v87.5.1939.1939 · Cited by 83
Self-citationDuprez, E., Ruchaud, S., Houge, G., Martin-Thouvenin, V., Valensi, F., Kastner, P., Berger, R., & Lanotte, M. (1992) · PubMed · Cited by 79
Miller, W. H., Warrell, R. P., Frankel, S., Jakubowski, A., Gabrilove, J. L., Muindi, J. R., & Dmitrovsky, E. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.24.1932 · Cited by 76
Self-citationRosenauer, A., Raelson, J., Nervi, C., Eydoux, P., DeBlasio, A., & Miller, W. J. (1996) · Blood · doi:10.1182/blood.v88.7.2671.bloodjournal8872671 · Cited by 75
Self-citationRapid Induction of CD38 Antigen on Myeloid Leukemia Cells by All trans-Retinoic Acid
Drach, J. W., Zhao, S. R., Malavasi, F., & Mehta, K. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.2080 · Cited by 72
Nervi, C., Poindexter, E. C., Grignani, F., Pandolfi, P. P., Coco, F. L., Avvisati, G., Pelicci, P. G., & Jetten, A. M. (1992) · PubMed · Cited by 63
Self-citationRetinoic acid nuclear receptor β inhibits breast carcinoma anchorage independent growth
Li, X., Shao, Z., Sheikh, M. S., Eiseman, J. L., Sentz, D. L., Jetten, A. M., Chen, J., Dawson, M. I., Aisner, S. C., Rishi, A. K., et al. (1995) · Journal of Cellular Physiology · doi:10.1002/jcp.1041650302 · Cited by 55
RARβ2-Mediated Growth Inhibition in HeLa Cells
Si, S. P., Lee, X., Tsou, H. C., et al. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0062 · Cited by 47
Fu, S., Consoli, U., Hanania, E. G., Zu, Z., Claxton, D. F., Andreeff, M., & Deisseroth, A. (1995) · PubMed · Cited by 18
Cited by
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
Lo-Coco, F., Avvisati, G., Vignetti, M., Thiede, C., Orlando, S. M., Iacobelli, S., Ferrara, F., Fazi, P., Cicconi, L., Di Bona, E., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1300874 · Cited by 1,611
Self-citationComplete Remission after Treatment of Acute Promyelocytic Leukemia with Arsenic Trioxide
Soignet, S. L., Maslak, P., Wang, Z.-G., Jhanwar, S., Calleja, E., Dardashti, L. J., Corso, D., DeBlasio, A., Gabrilove, J., Scheinberg, D. A., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391901 · Cited by 1,213
Melnick, A., & Licht, J. D. (1999) · Blood · doi:10.1182/blood.v93.10.3167.410k44_3167_3215 · Cited by 1,028
RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation
Tatham, M. H., Geoffroy, M.-C., Shen, L., Plechanovova, A., Hattersley, N., Jaffray, E. G., Palvimo, J. J., & Hay, R. T. (2008) · Nature Cell Biology · doi:10.1038/ncb1716 · Cited by 847
Arsenic degrades PML or PML–RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Lallemand-Breitenbach, V., Jeanne, M., Benhenda, S., Nasr, R., Lei, M., Peres, L., Zhou, J., Zhu, J., Raught, B., & de Thé, H. (2008) · Nature Cell Biology · doi:10.1038/ncb1717 · Cited by 734
Metadata
- Authors
- Shao, W., Fanelli, M., Ferrara, F. F., Riccioni, R., Rosenauer, A., Davison, K., Lamph, W. W., Waxman, S., Pelicci, P. G., Lo Coco, F., Avvisati, G., Testy, U., Peschle, C., Gambacorti-Passerini, C., Nervi, C., & Miller, W. H.
- Venue
- JNCI: Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 1998-01-21
- Volume
- 90
- Issue
- 2
- Pages
- 124-133
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2133935930
- Cited by
- 344
- References
- 47
- FWCI
- 10.02
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.